From: Frailty and solid-organ transplant candidates: a scoping review
All | Kidney [14, 19, 20, 25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49] | Liver [15, 58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86] | Lung [102,103,104,105,106,107,108,109,110,111,112,113,114,115,116] | |||
---|---|---|---|---|---|---|
# of studies examining at least one adverse outcome N (%) | 74 (73.3) | 6 (5.9) | 25 (24.8) | 28 (27.7) | 11 (10.9) | 4 (4.0) |
# of studies examining each adverse outcome N Mortality | 29 | 5 | 6 | 9 | 5 | 4 |
Length of staya | 20 | 4 | 4 | 5 | 5 | 2 |
Institutionalizationb | 4 | 0 | 1 | 2 | 0 | 1 |
Complications post-surgery | 9 | 0 | 3 | 4 | 1 | 1 |
Rehospitalizationc | 4 | 0 | 2 | 1 | 1 | 0 |
Functional decline | 4 | 0 | 1 | 1 | 1 | 1 |
Treatment changed | 2 | 2 | 0 | 0 | 0 | 0 |
Delirium | 1 | 0 | 1 | 0 | 0 | 0 |
Transplant rejectione | 1 | 0 | 0 | 1 | 0 | 0 |
Cognitive decline | 1 | 0 | 1 | 0 | 0 | 0 |
Quality of life decline | 4 | 0 | 2 | 1 | 1 | 0 |
Transplant Status (i.e., Delisting) | 17 | 3 | 6 | 5 | 2 | 1 |
Waitlist mortality | 21 | 1 | 6 | 12 | 2 | 0 |
Other | 18 | 1 | 10 | 4 | 3 | 0 |